Barring cisgender women from the Descovy trials was a bad call
MAURO PIMENTEL/AFP VIA GETTY IMAGES
Clinical trials for Descovy, Gilead's new HIV prevention drug, didn't include cisgender women, even though women make up half of people living with HIV.


No hay comentarios:
Publicar un comentario